Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website
  • Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe! 

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  17082 of 17156  at  9/23/2020 10:07:53 AM  by

Biotech_Jim


 In response to msg 17081 by  BelieverTim
view thread

Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD

 I continue to hold some ACAD shares, and the relative strength since its minirun from the $38s. 
 
 I also am trying to free up some funds for adding to this position. 
 
 These CNS plays have a good future, as more data and treatment options arrive on the scene. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 4     Views: 283
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
17084 Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD sphericalkutz 2 9/23/2020 12:42:02 PM






Financial Market Data provided by
.
Loading...